Neuralink's Blindsight chip, set for human trials in 2025, aims to restore vision for the blind by directly stimulating the brain's visual cortex.

Elon Musk has said that the first person to receive the Blindsight version of Neuralink will be treated this year.

Neuralink’s Blindsight implant aims to restore vision for the blind using a brain-computer interface, with future potential for superhuman sight beyond human capabilities.

All the Latest Game Footage and Images from BlindSight Event Zero A platform fighter with a deep and creative combo system built on fluid movement that is easy to pick up and rewarding to master ...

Elon Musks Neuralink is set to revolutionize vision restoration with its groundbreaking Blindsight technology, aimed at giving sight back to the blind. With human trials starting by 2025, this ...

The US Food and Drug Administration (FDA) has awarded a "Breakthrough Device" status to Neuralink’s experimental vision-restoring implant, Blindsight. This designation is intended to fast-track ...

Elon Musk's Neuralink has been awarded breakthrough status from the FDA for an implantable chip – dubbed Blindsight – that promises to restore the sight of people with vision impairment.

Elon Musk’s brain chip company, Neuralink, is aiming to achieve a major medical milestone by the end of 2025 with the first human implantation of its artificial visual prosthesis, Blindsight.